Novel rat model paves the way to advance COPD-associated cor pulmonale research

Novel rat model paves the way to advance COPD-associated cor pulmonale research

Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive pulmonary disease (COPD)-associated cor pulmonale. This model exhibits key characteristics, including chronic lung inflammation, pulmonary hypertension, and right ventricular hypertrophy. The new study details the potential for the model to unravel the complex interactions between lung…

Ritedose gets FDA approval for COPD inhalation drug - Columbia Business Report

​ Ritedose receives FDA approval for formoterol fumarate solution Supports Verona Pharma’s newly approved COPD drug Ohutuvayre Expanded capacity adds 180 million unit doses in 2024 COPD affects over 13 million diagnosed patients in the U.S. A Midlands pharmaceutical manufacturer has received FDA approval to combat an chronic inflammatory lung disease. Ritedose Pharmaceuticals, a division of The Ritedose Corp., secured FDA approval for its a…